Variation in TAS2R receptor genes explains differential bitterness of two common antibiotics.
Ontology highlight
ABSTRACT: For pharmaceuticals to deliver their full benefits with maximum efficacy, patients need to follow recommended dosing schedules, in terms of amount and frequency. Unfortunately, the aversive taste of many drugs, especially bitterness, can reduce patient compliance in oral liquid formulations. Given common genetic differences in bitter taste receptor genes (TAS2Rs), some individuals may be at increased risk for poor compliance due to heightened bitterness that becomes a barrier to proper use. Here we report on the sensory profile of two antibiotics, chloramphenicol and ofloxacin, investigating whether bitterness intensity associates with nominally functional TAS2R variants. Participants (n = 143) rated suprathreshold intensity on a general Labeled Magnitude Scale (gLMS)
SUBMITTER: Nolden AA
PROVIDER: S-EPMC9366911 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA